Stories from Chertsey, England

24.02.2016 – 01:02

Astellas Pharma Europe Limited
Britain Facing Social Care 'Time-bomb' with Thousands of People Underprepared to Look After Themselves in Old Age

Chertsey, England (ots/PRNewswire) - Experts say the knock-on effect of lack of planning for later life, as highlighted in poll conducted for this year's ASTELLAS INNOVATION DEBATE[TM],will further impact upon stretched NHS resources Results from a new survey for the annual Astellas Innovation Debate have ...

more
08.02.2016 – 16:16

Astellas Pharma GmbH
New Survey Shows UK Public Willing to Pay £10 for Missed GP Appointments to Support the NHS Amid Widespread Concerns About Government Spending on Healthcare

Chertsey, England (ots/PRNewswire) - Poll conducted in advance of this year's ASTELLAS INNOVATION DEBATE(TM) also demonstrates public are open to an additional 'health tax' to support improved NHS services, but clinicians fear additional charges will hit the poorest hardest Although the NHS is ranked as one of the ...

more
14.03.2013 – 10:48

Astellas Pharma Europe Limited
European Commission Approves New Pre-treatment Options for QUTENZA(TM) (8% Capsaicin Patch) in Peripheral Neuropathic Pain

Chertsey, England (ots/PRNewswire) - - For Healthcare and Business Media - Approval allows for more flexible approach to 8% capsaicin patch treatment of peripheralneuropathic pain The European Commission (EC) has approved expanded options for pre-treatment prior to use of QUTENZA (8% capsaicin patch). Before ...

more
11.01.2013 – 10:28

Astellas Pharma Europe Limited
New Class of Treatment for Overactive Bladder Approved in Europe

Chertsey, England (ots/PRNewswire) - A new treatment, BETMIGA(TM) (mirabegron) has received approval from the European Commission (EC) for the treatment of overactive bladder (OAB) symptoms in adults.[1] Mirabegron represents the first new class of oral treatment in OAB for over 30 years. Currently around half of patients discontinue OAB treatment after only three ...

more
06.11.2012 – 16:10

Astellas Pharma Europe Limited
Astellas Relocates European HQ and UK Operations to Accommodate new Growth

Chertsey, England (ots/PRNewswire) - Spectacular New Facilities, in Chertsey, Designed by Sir Norman Foster Astellas Pharma Europe Ltd. (APEL), the European Headquarters of Tokyo-based Astellas Pharma Inc., one of the world's top 20 pharmaceutical companies, today formally opens its new office in Hillswood Business Park, Chertsey. To accommodate the company's ...

more
19.10.2012 – 16:09

Astellas Pharma Europe Limited
Mirabegron Receives Positive CHMP Opinion for Treatment of Overactive Bladder Symptoms

Chertsey, England (ots/PRNewswire) - ASTELLAS PHARMA EUROPE Ltd. announced today that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion, recommending the granting of a marketing authorisation for BETMIGA[TM] (mirabegron) for the symptomatic treatment of urgency, increased micturition ...

more

1